FDA Commissioner Marty Makary told NBC News that the first psychedelic #drug could be approved in the U.S. as soon as this summer
UK-based biotech company Compass Pathways for a synthetic #psilocybin for treatment-resistant #depression
Usona Institute received a voucher for its work with psilocybin to treat major depressive disorder
New York-based Transcend Therapeutics for its experimental drug #methylone for #PTSD
https://www.nbcnews.com/health/health-news/fda-psychedelic-drugs-psilocybin-methylone-review-depression-ptsd-rcna341677

